Development of enterovirus 71 vaccines

References

• Schmidt NJ, Lennette EH, Ho HH. An apparently new enterovirus isolated from patients with disease of the central nervous system. J. Infect. Dis.129, 304–309 (1974).
   PubMed Web of Science ®Google Scholar
• Bible JM, Pantelidis P, Chan PK, Tong CY. Genetic evolution of enterovirus 71: epidemiological and pathological implications. Rev. Med. Virol.17, 371–379 (2007).
   PubMed Web of Science ®Google Scholar
• Chan YF, Sam IC, Abubakar S. Phylogenetic designation of enterovirus 71 genotypes and subgenotypes using complete genome sequences. Infect. Genet. Evol. DOI: 10.1016/j.meegid.2009.05.010 (Epub ahead of print) (2009).
   PubMedGoogle Scholar
• Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, Shimizu H. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat. Med.15, 794–797 (2009).
   PubMed Web of Science ®Google Scholar
• Yamayoshi S, Yamashita Y, Li J et al. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat. Med.15, 798–801 (2009).
   PubMed Web of Science ®Google Scholar
• Chang LY, Lin TY, Huang YC et al. Comparison of enterovirus 71 and coxsackievius A16 clinical illness during the Taiwan enterovirus epidemic, 1998. Ped. Infect. Dis. J.18, 1092–1096 (1999).
   PubMed Web of Science ®Google Scholar
• Gelfand HM, LeBlanc DR, Fox JP, Conwell DP. Studies on the development of natural immunity to poliomyelitis in Louisiana. II. Description and analysis of episodes of infection observed in study group households. Am. J. Hyg.65, 367–385 (1957).
   PubMedGoogle Scholar
• Kogon A, Spigland I, Frothingham TE et al. The Virus Watch Program: a continuing surveillance of viral infections in metropolitan New York families. VII. Observations on viral excretion, seroimmunity, intrafamilial spread and illness association in coxsackie and echovirus infections. Am. J. Epidemiol.89, 51–61 (1969).
   PubMed Web of Science ®Google Scholar
• Morens DM, Pallansch MA, Moore M. Polioviruses and other enteroviruses. In: Textbook of Human Virology (2nd Edition). Belshe RB (Ed.). Mosby Yearbook, St Louis, MO, USA, 427–497 (1991).
   Google Scholar
• Chung PW, Huang YC, Chang LY, Lin TY, Ning HC. Duration of enterovirus shedding in stool. J. Microl. Immunol. Infect.34, 167–170 (2001).
   PubMedGoogle Scholar
• Chang LY, Tsao KC, Hsia SH et al. Transmission and clinical features of enterovirus 71 infections in household contacts in Taiwan. JAMA291, 222–227 (2004).
   PubMed Web of Science ®Google Scholar
• Chang LY, King CC, Hsu KH et al. Risk factors of Enterovirus 71 infection and associated hand-foot-mouth-disease/herpangina in children. Pediatrics109, e88 (2002).
   PubMed Web of Science ®Google Scholar
• Chang LY, Lin TY, Hsu KH et al. Clinical features and risk factors of pulmonary oedema after enterovirus 71-related hand, foot, and mouth disease. Lancet354, 1682–1686 (1999).
   PubMed Web of Science ®Google Scholar
• Lin TY, Chang LY, Hsia SH et al. The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin. Infect. Dis.34, S52–S57 (2002).
   PubMedGoogle Scholar
• Chang LY, Hsia SH, Wu CT et al. Outcome of EV71 infections with or without stage-based management, 1998–2002. Pediatr. Infect. Dis. J.23, 327–331 (2004).
   PubMed Web of Science ®Google Scholar
• Chang LY, Huang LM, Gau SF et al. Neurodevelopment and cognition in children after enterovirus 71 infection. N. Engl. J. Med.356, 1226–1234 (2007).
   PubMed Web of Science ®Google Scholar
• Pallansch M, Roos RP. Enterovirus: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. In: Fields Virology (4th Edition). Fields BN, Knipe DM, Howley PM (Eds). Raven Press, NY, USA, 723–775 (2001).
   Google Scholar
• Plotkin SA, Vidor E. Poliovirus vaccine-inactivated. In: Vaccines (4th Edition). Plotkin SA, Orenstein WA, Offit PA (Eds). WB Saunders Co., PA, USA, 625–649 (2004).
   Google Scholar
• Wu CN, Lin YC, Fann C, Liao NS, Shih SR, Ho MS. Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine20, 895–904 (2001).
   PubMed Web of Science ®Google Scholar
• Foo DG, Alonso S, Chow VT, Poh CL. Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide. Microbes Infect.9, 1299–306 (2007).
   PubMed Web of Science ®Google Scholar
• Lu CY, Lee CY, Kao CL et al. Incidence and case–fatality rates resulting from the 1998 enterovirus 71 outbreak in Taiwan. J. Med. Virol.67, 217–223 (2002).
   PubMedGoogle Scholar
• Ooi EE, Phoon MC, Ishak B, Chan SH. Seroepidemiology of human enterovirus 71, Singapore. Emerg. Infect. Dis.8, 995–997 (2002).
   PubMed Web of Science ®Google Scholar
• Arita M, Nagata N, Iwata N et al. An attenuated strain of enterovirus 71 belonging to genotype A showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys. J. Virol.81, 9386–9395 (2007).
   PubMed Web of Science ®Google Scholar
• Luo ST, Chiang PS, Chao AS et al. Enterovirus 71 maternal antibodies in infants, Taiwan. Emerg. Infect. Dis.15, 581–584 (2009).
   PubMed Web of Science ®Google Scholar
• van der Sanden S, Koopmans M, Uslu G, van der Avoort H. Epidemiology of enterovirus 71 in The Netherlands, 1963 to 2008. J. Clin. Microbiol.47, 2826–2833 (2009).
   PubMed Web of Science ®Google Scholar
• Khetsuriani N, Lamonte-Fowlkes A, Oberst S, Pallansch MA. Enterovirus surveillance – United States, 1970>–2005. MMWR Surveill. Summ.55, 1–20 (2006).
   PubMedGoogle Scholar
• Ang LW, Koh BK, Chan KP, Chua LT, James L, Goh KT. Epidemiology and control of hand, foot and mouth disease in Singapore, 2001–2007. Ann. Acad. Med. Singapore38, 106–112 (2009).
   PubMed Web of Science ®Google Scholar
• Podin Y, Gias EL, Ong F et al. Sentinel surveillance for human enterovirus 71 in Sarawak, Malaysia: lessons from the first 7 years. BMC Public Health6, 180 (2006).
   PubMed Web of Science ®Google Scholar
• Tu PV, Thao NT, Perera D et al. Epidemiologic and virologic investigation of hand, foot, and mouth disease, southern Vietnam, 2005. Emerg. Infect. Dis.13, 1733–1741 (2007).
   PubMed Web of Science ®Google Scholar
• Chumakov M, Voroshilova M, Shindarov L et al. Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria. Arch. Virol.60, 329–340 (1979).
   PubMed Web of Science ®Google Scholar
• Nagy G, Takatsy S, Kukan E, Mihaly I, Domok I. Virological diagnosis of enterovirus type 71 infections: experiences gained during an epidemic of acute CNS diseases in Hungary in 1978. Arch. Virol.71, 217–227 (1982).
   PubMed Web of Science ®Google Scholar
• Chan LG, Parashar UD, Lye MS et al. Deaths of children during an outbreak of hand, foot, and mouth disease in Sarawak, Malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin. Infect. Dis.31, 678–683 (2000).
   PubMed Web of Science ®Google Scholar
• Ooi MH, Wong SC, Podin Y et al. Human enterovirus 71 disease in Sarawak, Malaysia: a prospective clinical, virological, and molecular epidemiological study. Clin. Infect. Dis.44, 646–656 (2007).
   PubMed Web of Science ®Google Scholar
• Ooi MH, Wong SC, Mohan A et al. Identification and validation of clinical predictors for the risk of neurological involvement in children with hand, foot, and mouth disease in Sarawak. BMC Infect. Dis.9, 3 (2009).
   PubMedGoogle Scholar
• Ho M, Chen ER, Hsu KH et al. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N. Engl. J. Med.341, 929–935 (1999).
   PubMed Web of Science ®Google Scholar
• Liu D. Enterovirus infection in Chinese Taipei: 10 years of experience and our future prospects. Presented at: APEC Conference for the Surveillance, Treatment, Laboratory Diagnosis and Vaccine Development of Enteroviruses. Taipei, Taiwan, 14–15 May 2009.
   Google Scholar
• Tseng FC, Huang HC, Chi CY et al. Epidemiological survey of enterovirus infections occurring in Taiwan between 2000 and 2005: analysis of sentinel physician surveillance data. J. Med. Virol.79, 1850–1860 (2007).
   PubMed Web of Science ®Google Scholar
• Chan KP, Goh KT, Chong CY, Teo ES, Lau G, Ling AE. Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore. Emerg. Infect. Dis.9, 78–85 (2003).
   PubMed Web of Science ®Google Scholar
• AbuBakar S, Sam IC, Yusof J et al. Enterovirus 71 outbreak, Brunei. Emerg. Infect. Dis.15, 79–82 (2009).
   PubMed Web of Science ®Google Scholar
• Yang F, Ren L, Xiong Z et al. Enterovirus 71 outbreak in the People’s Republic of China in 2008. J. Clin. Microbiol.47, 2351–2352 (2009).
   PubMed Web of Science ®Google Scholar
• Zhang Y, Tan XJ, Wang HY et al. An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China. J. Clin. Virol.44, 262–267 (2009).
   PubMed Web of Science ®Google Scholar
• Xiao D. Strategy of prevention and control for HFMD in China. Presented at: APEC Conference for the Surveillance, Treatment, Laboratory Diagnosis and Vaccine Development of Enteroviruses. Taipei, Taiwan, 14–15 May 2009.
   Google Scholar
• Mizuta K, Aoki Y, Suto A et al. Cross-antigenicity among EV71 strains from different genogroups isolated in Yamagata, Japan, between 1990 and 2007. Vaccine27, 3153–3158 (2009).
   PubMed Web of Science ®Google Scholar
• Diedrich S, Weinbrecht A, Schreier E. Seroprevalence and molecular epidemiology of enterovirus 71 in Germany. Arch. Virol.154, 1139–1142 (2009).
   PubMed Web of Science ®Google Scholar
• Castro CM, Cruz AC, Silva EE, Gomes Mde L. Molecular and seroepidemiologic studies of Enterovirus 71 infection in the State of Para, Brazil. Rev. Inst. Med. Trop. Sao Paulo47, 65–71 (2005).
   PubMedGoogle Scholar
• Kung SH, Wang SF, Huang CW, Hsu CC, Liu HF, Yang JY. Genetic and antigenic analyses of enterovirus 71 isolates in Taiwan during 1998–2005. Clin. Microbiol. Infect.13, 782–787 (2007).
   PubMed Web of Science ®Google Scholar
• Chiang P, Lin TY, Li WC et al. Reemergence of enterovirus 71 epidemic in Taiwan, 2008: clinical, virological and serological characteristics. Presented at: Infectious Disease Society of American 47th Annual Meeting. Philadelphia, PA, USA, 29 October–1 November 2009.
   Google Scholar
• Chiu CH, Chu C, He CC, Lin TY. Protection of neonatal mice from lethal enterovirus 71 infection by maternal immunization with attenuated Salmonella enterica serovar Typhimurium expressing VP1 of enterovirus 71. Microbes Infect.8, 1671–1678 (2006).
   PubMed Web of Science ®Google Scholar
• Chung YC, Ho MS, Wu JC et al. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Vaccine26, 1855–1862 (2008).
   PubMed Web of Science ®Google Scholar
• Wu TC, Wang YF, Lee YP et al. Immunity to avirulent enterovirus 71 and coxsackie A16 virus protects against enterovirus 71 infection in mice. J. Virol.81, 10310–10315 (2007).
   PubMed Web of Science ®Google Scholar
• Wu SC, Liu CC, Lian WC. Optimization of microcarrier cell culture process for the inactivated enterovirus type 71 vaccine development. Vaccine22, 3858–3864 (2004).
   PubMedGoogle Scholar
• Chen HF, Chang MH, Chiang BL, Jeng ST. Oral immunization of mice using transgenic tomato fruit expressing VP1 protein from enterovirus 71. Vaccine24, 2944–2951 (2006).
   PubMed Web of Science ®Google Scholar
• Foo DG, Alonso S, Phoon MC, Ramachandran NP, Chow VT, Poh CL. Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides. Virus Res.125, 61–68 (2007).
   PubMed Web of Science ®Google Scholar
• Tung WS, Bakar SA, Sekawi Z, Rosli R. DNA vaccine constructs against enterovirus 71 elicit immune response in mice. Genet. Vaccines Ther.5, 6 (2007).
   PubMedGoogle Scholar